Galectin Therapeutics Inc. Common Stock — Institutional Ownership
Which tracked institutions hold GALT, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
17
Funds holding
$22111153
Total value held
Buying
11 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $13865957 | 2988353 | +2189116 | +273.90% |
| 2 | State Street Corp | $2634495 | 567779 | +309347 | +119.70% |
| 3 | Northern Trust Corp | $1793569 | 386545 | +256097 | +196.32% |
| 4 | Ubs Group Ag | $1017641 | 219319 | +219319 | NEW BUY |
| 5 | Bank Of New York Mellon Corp | $490644 | 105742 | +105742 | NEW BUY |
| 6 | Morgan Stanley | $433724 | 93475 | -10930 | -10.47% |
| 7 | Goldman Sachs Group Inc | $345931 | 74554 | -110183 | -59.64% |
| 8 | Truist Financial Corp | $315520 | 68000 | — | Held |
| 9 | Bank Of America Corp /De/ | $267798 | 57715 | +3853 | +7.15% |
| 10 | Wells Fargo & Company/Mn | $216646 | 46691 | +40392 | +641.24% |
| 11 | Pinnacle Financial Partners, Inc. | $193256 | 41650 | — | Held |
| 12 | Jpmorgan Chase & Co | $184825 | 37188 | +26145 | +236.76% |
| 13 | Invesco Ltd. | $119211 | 25692 | +25692 | NEW BUY |
| 14 | Citigroup Inc | $104252 | 22468 | +11243 | +100.16% |
| 15 | Raymond James Financial Inc | $65966 | 14217 | -750 | -5.01% |
| 16 | Barclays Plc | $53718 | 11577 | -100271 | -89.65% |
| 17 | Royal Bank Of Canada | $8000 | 1632 | +565 | +52.95% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.